The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors.
Zhao R, Shao H, Shi G, Qiu Y, Tang T, Lin Y, Chen S, Huang C, Liao S, Chen J, Fu H, Liu J, Xu B, Liu T, Zhang Y, Yang Y.
Zhao R, et al. Among authors: shao h.
J Natl Cancer Cent. 2023 Nov 10;4(1):86-92. doi: 10.1016/j.jncc.2023.11.001. eCollection 2024 Mar.
J Natl Cancer Cent. 2023.
PMID: 39036380
Free PMC article.